- AU$662.12m
- AU$940.36m
- AU$2.97bn
- 36
- 71
- 72
- 62
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 16.56 | ||
| PEG Ratio (f) | 0.69 | ||
| EPS Growth (f) | 31.47% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.13 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.14 | ||
| EV to EBITDA | 12.46 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 10.92% | ||
| Return on Equity | 6.06% | ||
| Operating Margin | 1.13% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 231.88 | 235.86 | 237.75 | 2,187.34 | 2,969.89 | 3,762.18 | 3,922.8 | 65.86% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +2.96 | +7.84 | -45.64 | +92.31 | +25 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Paragon Care Limited is an Australia-based company, which is engaged in the healthcare sector. The Company is a provider of medical equipment, devices, pharmaceuticals, and consumables to the healthcare markets in Australia, New Zealand and Asia. The Company operates through two segments ParagonCare and CH2 Holdings. The ParagonCare segment incorporates a provider of medical equipment, devices and consumables to the healthcare markets. The CH2 Holdings segment incorporates distribution of pharmaceutical, medical consumables, nutritional and over the counter products to the healthcare market. Its product portfolio includes critical care, diagnostic & scientific, eye care, medical products & consumables, neonatal, orthopedics, service, surgical, technology & connectivity, urology, veterinary and aesthetics. Its brands include ParagonCare Immulab, ParagonCare LabGear, Meditron, Medtech Solutions, Western Biomedical, ParagonCare REM SYSTEMS, and ParagonCare Surgical Specialties.
Directors
- Shane Tanner NEC
- Phil Nicholl CEO
- Stephen Munday CFO (54)
- Michael Rice OTH (41)
- Melanie Leydin SEC
- Mark Simari NED (50)
- Geoffrey Sam NID (65)
- Brent Stewart NID
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 3rd, 1994
- Public Since
- October 15th, 1999
- No. of Shareholders
- 5,881
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Australian Stock Exchange - SEATS- Shares in Issue
- 1,655,305,389
- Address
- Level 4, 96-100 Albert Road, SOUTH MELBOURNE, 3205
- Web
- https://paragoncare.com.au/contact
- Phone
- +61 300369559
- Auditors
- RSM Australia Partners
Upcoming Events for PGC
Similar to PGC
4DMedical
Australian Stock Exchange - SEATS
Adherium
Australian Stock Exchange - SEATS
Ansell
Australian Stock Exchange - SEATS
Anteris Technologies
Australian Stock Exchange - SEATS
Aroa Biosurgery
Australian Stock Exchange - SEATS
FAQ
What is the Paragon Care share price?
As of Today at 22:33 UTC, shares in Paragon Care are trading at AU$0.40. This share price information is delayed by 15 minutes.
How has the Paragon Care share price performed this year?
Shares in Paragon Care last closed at AU$0.40 and the price had moved by +17.65% over the past 365 days. In terms of relative price strength the Paragon Care share price has outperformed the ASX All Ordinaries Index by +13.38% over the past year.
What are the analyst and broker recommendations for Paragon Care?
The overall consensus recommendation for Paragon Care is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Paragon Care dividend yield?
Paragon Care does not currently pay a dividend.
Does Paragon Care pay a dividend?
Paragon Care does not currently pay a dividend.
When does Paragon Care next pay dividends?
Paragon Care does not currently pay a dividend.
How do I buy Paragon Care shares?
To buy shares in Paragon Care you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Paragon Care?
As of the previous close price of AU$0.40, shares in Paragon Care had a market capitalisation of AU$662.12m.
Where are Paragon Care shares listed?
Here are the trading details for Paragon Care:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: PGC
What kind of share is Paragon Care?
Based on an overall assessment of its quality, value and momentum Paragon Care is currently classified as a Turnaround. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Paragon Care share price forecast for 2025?
The analyst consensus target price for shares in Paragon Care is AU$0.54. That is 35.75% above the last closing price of AU$0.40.
Analysts covering Paragon Care currently have a consensus Earnings Per Share (EPS) forecast of AU$0.02 for the next financial year.
Find out moreWhat is the trend in the Paragon Care share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Paragon Care. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -7.53%.
As of the last closing price of AU$0.40, shares in Paragon Care were trading -12.73% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Paragon Care PE Ratio?
The Paragon Care PE ratio based on its reported earnings over the past 12 months is 16.56. The shares last closed at AU$0.40.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Paragon Care?
Paragon Care's management team is headed by:
- Shane Tanner - NEC
- Phil Nicholl - CEO
- Stephen Munday - CFO
- Michael Rice - OTH
- Melanie Leydin - SEC
- Mark Simari - NED
- Geoffrey Sam - NID
- Brent Stewart - NID